Cargando…
Oligometastatic Disease Management: Finding the Sweet Spot
Hematogenous dissemination represents a common manifestation of squamous cell carcinoma of the head and neck, and the recommended therapeutic options usually consist of systemically administered drugs with palliative intent. However, mounting evidence suggests that patients with few and slowly progr...
Autores principales: | Szturz, Petr, Nevens, Daan, Vermorken, Jan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783387/ https://www.ncbi.nlm.nih.gov/pubmed/33415080 http://dx.doi.org/10.3389/fonc.2020.617793 |
Ejemplares similares
-
Estimating the Prevalence of a True Oligometastatic Disease
por: Szturz, Petr, et al.
Publicado: (2022) -
Steering decision making by terminology: oligometastatic versus argometastatic
por: Szturz, Petr, et al.
Publicado: (2022) -
Oligometastatic Cancer: Key Concepts and Research Opportunities for 2021 and Beyond
por: Szturz, Petr, et al.
Publicado: (2021) -
Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck
por: Szturz, Petr, et al.
Publicado: (2016) -
Editorial: Head and neck cancer in the elderly
por: Szturz, Petr, et al.
Publicado: (2023)